Document is current
Any future updates will be listed below
-
Authors
Vandenabeele, Marjan
Veys, Lien
Lemmens, Sophie
Hadoux, Xavier
Gelders, Géraldine
Masin, Luca
Serneels, Lutgarde
Theunis, Jan
Saito, Takashi
Saido, Takaomi C.
Jayapala, Murali
De Boever, Patrick
De Strooper, Bart
Stalmans, Ingeborg
van Wijngaarden, Peter
Moons, Lieve
De Groef, Lies http://orcid.org/0000-0002-3329-3474
-
Funding
Funding for this research was provided by:
Fonds Wetenschappelijk Onderzoek (PhD fellowship)
Fonds Wetenschappelijk Onderzoek (PhD fellowship)
Fonds Wetenschappelijk Onderzoek (PhD fellowship)
Fonds Wetenschappelijk Onderzoek (senior postdoctoral fellowship)
Alzheimer's Research Foundation
Horizon 2020
State Government of Victoria
H & L Hecht Trust
Yulgilbar Alzheimer’s Research Program
- License Information
-
More Information
Article History
Received: 15 October 2020
Accepted: 13 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: All animal experiments were performed according to the European directive 2010/63/EU and approved by the KU Leuven institutional ethics committee for animal research.
: Not applicable.
: The authors declare the following competing interests: XH and PvW have filed an International (PCT) Patent Application No PCT/AU2019/000003 relating to retinal hyperspectral imaging. They are co-founders of Enlighten Imaging PTY LTD, a start-up company focused on developing novel retinal imaging solutions for neurological and retinal diseases.
